Dr. Gerald W Dryden, MD, Ph.D
Claim this profileUniversity Of Louisville
Studies Ulcerative Colitis
Studies Eosinophilic Esophagitis
10 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials Gerald W Dryden, MD, Ph.D is currently running
Hyperbaric Oxygen Therapy
for Ulcerative Colitis
Chronic intestinal hypoxia and accompanying mucosal inflammation is a hallmark of ulcerative colitis (UC). Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen under increased atmospheric pressure to increase tissue oxygenation. Two small prospective randomized controlled trials have demonstrated that the delivery of HBOT to UC patients hospitalized for acute moderate to severe flares results in improved remission rates and avoidance of in-hospital progression to biologics, small molecules, or colectomy. In this larger trial the study aims to confirm the treatment benefits of HBOT for hospitalized UC patients and study the immune-microbe mechanisms underpinning treatment response.
Recruiting0 awards N/A
Genetic Study
for Inflammatory Bowel Disease
The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population. African Americans with or without Crohn's disease or ulcerative colitis are eligible to join. If you agree to join the study, the investigators will ask for information about your health. The investigators will also ask you to give us a blood sample so that they may discover the genes that cause IBD. The blood sample may be collected at Johns Hopkins or any local facility convenient to you.
Recruiting1 award N/A2 criteria
More about Gerald W Dryden, MD, Ph.D
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Gerald W Dryden, MD, Ph.D has experience with
- ABX464
- Placebo
- CC-93538
- Ozanimod
- Cendakimab
- CYP Substrates
Breakdown of trials Gerald W Dryden, MD, Ph.D has run
Ulcerative Colitis
Eosinophilic Esophagitis
Colitis
Inflammatory Bowel Disease
Gastrointestinal Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gerald W Dryden, MD, Ph.D specialize in?
Gerald W Dryden, MD, Ph.D focuses on Ulcerative Colitis and Eosinophilic Esophagitis. In particular, much of their work with Ulcerative Colitis has involved treating patients, or patients who are undergoing treatment.
Is Gerald W Dryden, MD, Ph.D currently recruiting for clinical trials?
Yes, Gerald W Dryden, MD, Ph.D is currently recruiting for 3 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Gerald W Dryden, MD, Ph.D has studied deeply?
Yes, Gerald W Dryden, MD, Ph.D has studied treatments such as ABX464, Placebo, CC-93538.
What is the best way to schedule an appointment with Gerald W Dryden, MD, Ph.D?
Apply for one of the trials that Gerald W Dryden, MD, Ph.D is conducting.
What is the office address of Gerald W Dryden, MD, Ph.D?
The office of Gerald W Dryden, MD, Ph.D is located at: University Of Louisville, Louisville, Kentucky 40202 United States. This is the address for their practice at the University Of Louisville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.